While NaAc administration promotes DNL through ACLY-dependent acetyl-CoA synthesis in hepatocytes [35], chronic exposure improves insulin sensitivity by activating GPR43 in HFD-induced NAFLD models [36]. Here, FFAR2 is linked to metabolic dysfunction-associated steatotic liver disease.